Kezar Life Sciences, Inc.
KZRDelisted May 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645666
Kezar Life Sciences, Inc. was delisted on May 11, 2026; its insiders filed their last Form 4 on May 11, 2026; 43 institutions reported holding it in 13F filings for Q1 2026, worth $32.8M in total; no superinvestor held it.
13F holders, Q1 2026
Institutional positions in Kezar Life Sciences, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
KZR is no longer listed, so this page shows Q1 2026. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 43
- +3 vs. Q4 2025
- Shares held
- 4.43M
- +311.3K (+7.6%) vs. Q4 2025
- Total value
- $32.8M
- +$6.95M (+26.8%) vs. Q4 2025
- New holders
- 13
- 8 more added
- Sold out
- 10
- 9 more reduced
3 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KZR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 43 | $32.8M |
| Q4 2025 | 43 | $28.1M |
| Q3 2025 | 39 | $16.5M |
| Q2 2025 | 40 | $20.5M |
| Q1 2025 | 41 | $21.1M |
| Q4 2024 | 43 | $28.2M |
| Q3 2024 | 60 | $31.6M |
| Q2 2024 | 81 | $23.6M |
| Q1 2024 | 85 | $40.3M |
| Q4 2023 | 81 | $46.8M |
| Q3 2023 | 82 | $66.0M |
| Q2 2023 | 104 | $139.4M |
| Q1 2023 | 137 | $188.1M |
| Q4 2022 | 123 | $404.2M |
| Q3 2022 | 132 | $495.5M |
| Q2 2022 | 127 | $454.0M |
| Q1 2022 | 123 | $734.1M |
| Q4 2021 | 107 | $674.1M |
| Q3 2021 | 77 | $242.7M |
| Q2 2021 | 75 | $150.1M |
| Q1 2021 | 83 | $158.0M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Kezar Life Sciences, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Barclays PLC | 1 | $7 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 13 | $96 | 0.00% | −27−67.5% | Reduced |
| Allworth Financial LP | 50 | $371 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 89 | $660 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 109 | $812 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 262 | $1.94K | 0.00% | −302−53.5% | Reduced |
| Royal Bank of Canada | 322 | $2.00K | 0.00% | +210+187.5% | Added |
| Caitong International Asset Management Co., Ltd | 308 | $2.29K | 0.00% | +308 | New |
| Vanguard Global Advisers, LLC | 1,737 | $12.9K | 0.00% | +1,737 | New |
| GWM Advisors LLC | 2,176 | $16.1K | 0.00% | +2,176 | New |
| Morgan Stanley | 4,285 | $31.8K | 0.00% | −1,400−24.6% | Reduced |
| Wells Fargo & Company | 5,796 | $43.0K | 0.00% | −40−0.7% | Reduced |
| FMR LLC | 10,208 | $75.7K | 0.00% | +10,000+4,807.7% | Added |
| Northern Trust Corp | 13,763 | $102.1K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 16,210 | $120.3K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 19,495 | $144.7K | 0.00% | +19,495 | New |
| Equitec Proprietary Markets, LLC | 19,500 | $144.7K | 0.33% | +19,500 | New |
| Jane Street Group, LLC | 21,367 | $158.5K | 0.00% | +21,367 | New |
| Vazirani Asset Management LLC | 22,000 | $163.2K | 0.38% | −26,428−54.6% | Reduced |
| Yakira Capital Management, Inc. | 24,000 | $178.1K | 0.05% | +24,000 | New |
| State Street Corp | 27,093 | $201.0K | 0.00% | 00.0% | Unchanged |
| RBF Capital, LLC | 28,144 | $208.8K | 0.01% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 30,334 | $225.1K | 0.00% | +3,791+14.3% | Added |
| Vanguard Fiduciary Trust Co | 41,201 | $305.7K | 0.00% | +41,201 | New |
| Torno Capital, LLC | 48,479 | $359.7K | 0.15% | +28,479+142.4% | Added |
| Credit Industriel Et Commercial | 53,600 | $397.7K | 0.06% | +53,600 | New |
| Citadel Advisors LLC | 59,403 | $440.8K | 0.00% | +59,403 | New |
| Geode Capital Management, LLC | 60,988 | $452.6K | 0.00% | −7,179−10.5% | Reduced |
| Aldebaran Capital, LLC | 80,335 | $596.1K | 0.46% | −295−0.4% | Reduced |
| Groupe la Francaise | 80,400 | $596.6K | 0.01% | +80,400 | New |
| ADAR1 Capital Management, LLC | 81,933 | $607.9K | 0.04% | −35,507−30.2% | Reduced |
| BlackRock, Inc. | 100,064 | $742.5K | 0.00% | +1,380+1.4% | Added |
| Ikarian Capital, LLC | 102,211 | $758.4K | 0.11% | 00.0% | Unchanged |
| Peapod Lane Capital LLC | 126,692 | $924.5K | 0.76% | −70.0% | Reduced |
| Millennium Management LLC | 142,050 | $1.05M | 0.00% | +142,050 | New |
| Acadian Asset Management LLC | 151,630 | $1.12M | 0.00% | +26,259+20.9% | Added |
| Renaissance Technologies LLC | 188,426 | $1.40M | 0.00% | +57,141+43.5% | Added |
| Affinity Asset Advisors, LLC | 229,076 | $1.70M | 0.10% | 00.0% | Unchanged |
| Rangeley Capital, LLC | 243,073 | $1.80M | 1.95% | +157,147+182.9% | Added |
| Vanguard Capital Management LLC | 290,529 | $2.16M | 0.00% | +290,529 | New |
| Tang Capital Management LLC | 664,314 | $4.93M | 0.25% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 716,759 | $5.32M | 0.14% | 00.0% | Unchanged |
| BML Capital Management, LLC | 720,787 | $5.35M | 3.44% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 0 | $0 | 0.00% | −276,754−100.0% | Sold out |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −156,179−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −52,929−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −51,638−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Shay Capital LLC | 0 | $0 | 0.00% | −33,699−100.0% | Sold out |
| Nano Cap New Millennium Growth Fund L P | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −11,312−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −122−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −94−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |
| CIBC Private Wealth Group, LLC | – | – | – | – | Not filed |